A Hungarian and US national, Pali started his career as a medical practitioner before serving in a wide range of pricing and reimbursement roles for multinational healthcare companies. He led Global Pricing and Reimbursement Strategy for Public Sector Products at Wyeth (Pfizer) before moving to Merck & Co. to serve as Director of Global Pricing & Reimbursement Strategy. At Merck he was responsible for developing P&R strategies for a broad range of developmental pharmaceutical and vaccine products and led in-line product pricing for Central and Eastern Europe and for the Merck/Schering-Plough Cholesterol partnership. He later moved to Kantar Health where he led two account teams covering the overall Kantar Heath offer such as real world, clinical, market access and market research in addition to brand/molecule related consultancy for two leading pharma companies. He now serves as a consultant across CEE.